載入...
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
Cancer immunotherapy has emerged as a promising cancer treatment. However, the presence of immune-refractory tumor cells limits its clinical success by blocking amplification of anti-tumor immunity. Previously, we found that immune selection by immunotherapy drives the evolution of tumors toward mul...
Na minha lista:
| 發表在: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6987099/ https://ncbi.nlm.nih.gov/pubmed/31992715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-019-14259-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|